Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Tasly Pharmaceutical describes platelet aggregation inhibitors

Jan. 13, 2017

DSMB recommends continuation of Evgen's phase II trial of SFX-01 in subarachnoid hemorrhage

Jan. 12, 2017

Targeting Pol I as a novel therapeutic strategy for preventing arterial restenosis

Jan. 11, 2017

Aralez Pharmaceuticals submits MAA for PA-10040 in E.U.

Jan. 10, 2017

University College Dublin patents prostanoid TP antagonists

Jan. 10, 2017

Corsair Pharma reports prostacyclin analogues for PAH

Jan. 9, 2017

APT Therapeutics and AstraZeneca enter agreement regarding APT-102

Jan. 9, 2017

Vascular Strategies patents mTOR inhibitors

Jan. 5, 2017

Global Blood Therapeutics develops KLKB1 inhibitors

Jan. 5, 2017

Restoration of PI3K/Akt/GSK-3beta/ROS signaling pathway for arrhythmias after infarction

Jan. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...